This American Cancer Society sponsored study provides new knowledge about an actual intervention to optimize surgical rates for early stage, non-small cell lung cancer and mitigate disparities in the care of African-American patients with this disease. A successful intervention would have a large impact on cancer disparities and could be generalized across cancer care and other clinical settings in which time-critical decisions are made.
Principal Investigator: Samuel Cykert, M.D.
Primary Funding Source: American Cancer Society
Total Project Period: 7/1/11 – 6/30/16